Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis

Completed · Phase 4

Conditions studied: Atopic Dermatitis

In brief

This study compares the effectiveness of two topical creams for atopic dermatitis in pediatric subjects. Subjects will be randomly assigned to use one of the two creams twice daily for 6 weeks or until clear.

Key facts

Study ID

NCT00828412

Run by

Promius Pharma, LLC

People needed

100

Starts

2009-03-01

Expected to finish

2009-08-01

Last updated by the study team

2017-01-30

Who can join

Age: 0 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• at least 3 months of age and less than 13 years of age
• atopic dermatitis of moderate severity

You may not qualify if…

• pregnant or lactating
• treatment of atopic dermatitis with topical product in the 14 days prior to Baseline
• treatment of atopic dermatitis with systemic product in the 30 days prior to Baseline
• serious or uncontrolled medical condition
• active infection
• significant use of inhaled, intranasal, or intraocular corticosteroid

Where it is running

• National Jewish Health — Denver, Colorado, United States
• Northwestern University — Chicago, Illinois, United States
• Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States
• Dermatology Research Associates — Cincinnati, Ohio, United States
• University of Texas — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.